Once-weekly semaglutide 2·4 mg in an Asian population with obesity, defined as BMI ≥25 kg/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial
用户QMBD82MgGHts
1个月前
43
10
已完结
1. 系统已在2025-11-11 15:40:04对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/S2213-8587(25)00164-0
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213858725001640
其他信息:
出版社: Elsevier BV
作者: Soo Lim; Supawan Buranapin; Xiaolei Bao; María Quiroga; Kyung Hee Park; Jee-Hyun Kang; Anders Rasmussen Rinnov; Arisara Suwanagool
